Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Phase IIa Mechanistic Study of Anti-GM-CSF (GSK3196165) with Methotrexate Treatment in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response to Methotrexate Genovese, M. C., Berkowitz, M., Conaghan, P. G., Davy, K., Inman, D., Fisheleva, E., Gupta, A., Janiczek, R., Layton, M., Mitchell, N., Patel, J., Smith, J. E., Williamson, R., Tak, P. WILEY. 2018
View details for Web of Science ID 000447268904243